Summary of the American College for Advancement in Medicine November 2007 Conference on Integrative Medicine: Advancing Science and Clinical Practice by Speight, Neal & Hynote, Eleanor D.
Advance Access Publication 20 March 2008 eCAM 2009;6(3)415–420
doi:10.1093/ecam/nen020
Meeting Report
Summary of the American College for Advancement in
Medicine November 2007 Conference on Integrative
Medicine: Advancing Science and Clinical Practice
Neal Speight
1 and Eleanor D. Hynote
2
1The Center for Wellness 1258 Mann Drive Ste 100, Matthews, NC 28105 and
2Phoenix WellCare 3417 Valle Verde
Rd Napa, CA 94558, USA
The autumn 2007 session of the American College for
Advancement in Medicine’s International Educational
Conference on Complementary, Alternative and Integra-
tive Medicine (CAIM) took place between November 14
and November 18at the Sheraton Wild Horse Pass Resort
in Chandler, Arizona, USA. Over 400 physicians gathered
at ACAM’s (American College for Advancement in
Medicine) ‘Integrative Medicine: Advancing Science and
Clinical Practice’ to learn the latest science on a variety of
illnesses. From topics in cancer and musculoskeletal
disorders, to the science of lipids, these were cutting edge
lectures from leading scientists and clinicians around the
country.
ACAM is a not-for-profit medical society dedicated to
the education of physicians and allied health care profes-
sionals. As the leading voice in CAIM for over 30 years,
ACAM strives to bring the best of nutritional and
environmental research into the arena of clinical practice.
During the meeting, Dr Ken Bock turned over the
presidency to Dr Jeanne Drisko, the Riordan Professor
of Orthomolecular Medicine and Director of the Program
in Integrative Medicine Complementary and Alternative
Therapies at the University of Kansas Medical Center.
Dr Drisko’s academic background and forward thinking
leadership will help guide ACAM through the next 2
years. She has continuously demonstrated her commit-
ment to providing advanced education to physicians
through her collaborative efforts within the CAIM
community and her research efforts at KUMC.
Her plans include expanding Dr Bock’s successful
legacy of building bridges by reaching out to the aca-
demic CAIM physicians in the Consortium of Academic
Health Centers for Integrative Medicine. We look
forward to Dr Drisko’s visionary efforts on behalf of
our organization.
ACAM unveiled it’s first Integrative Health Guideline
on the management of hypercholesterolemia. Graciously
sponsored by Employers Resource and authored by Dr
Mark Houston and colleagues, this effort promises to be
the first in a series that brings fully integrated guidelines
to bear on the management of degenerative illnesses.
The pre-conference workshop on Hormone Replace-
ment therapy was co-chaired by our incoming president,
Dr Jeanne Drisko and president elect Dr Eleanor
Hynote. Presenters included Dr David Rosensweet,
Dr Eugene Shippen and Dr Jonathan Wright. Emphasis
was placed on individualizing bioidentical hormone
replacement therapy. From titration methods of bio-
idientical hormones to the benefits of iodine in fibrocystic
breast disease this workshop was filled with practical
information.
ACAM’s pre-conference workshop on chelation ther-
apy was co-chaired by Dr James Biddle and Dr Jeffery
Morrison. Chelating agents are molecules known
for their strong affinity for heavy metals and their
ability to remove them from the body. The workshop
consisted of lectures describing the general history and
biochemical role of chelation therapy, the indications for
varied chelating agents, abnormal lab parameters in the
setting of heavy metals and the rationale of this
therapy in the treatment of chronic degenerative diseases
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Summary of Presentations
Gina Nick, NMD, PhD
Medical Director of Serenity Wellness Center, Orange
County, CA. E-mail: gnick@ltponline.com
Inflammation in the brain and depression: advances in the
recognition and treatment of sickness syndrome
Dr Nick reviewed the concept of sickness syndrome,
a recently coined term she uses to describe chronic
elevation of cortisol and the subsequent increase in
inflammatory cytokines TNF alpha and IL-6. These
inflammatory markers lead to associated depression and
poor mental function. She reviewed the importance of
detoxication and restoration of adrenal gland and brain
function through proper diet, caloric restriction and
herbal nutrients. Lastly she emphasized the importance
of assessing hormonal balance and the utilization of
prayer and meditation in regulating vagal output and
production of inflammatory cytokines.
James M. Wright, MD, PhD
Professor—Department of Anesthesiology, Pharmacology
and Therapeutics and Department of Medicine at the
University of BC, Vancouver, Canada.
Coordinating Editor—Cochrane Hypertension Review
Group. E-mail: Jim.wright@ti.ubc.ca
Are lipid lowering guidelines evidence based?
Dr Wright’s lecture discussed bias in clinical guidelines
identifying those who are likely to benefit from statin
therapy and those who are not. He reviewed the fact that
all major clinical guidelines ultimately mandate different
percentages of patients receive statins and then proceeded
to explain the bias inherent in them. He highlighted the
fact that serious adverse event data is often missing in
primary prevention trials and that this data must be
reviewed in order to conclude a true ‘net health benefit’
in the various populations studied. He concluded that
statins do not reduce mortality in primary prevention
populations (those patients with risk factors, but no
proven vascular disease) and their use in this population
should be reconsidered. In fact, after a full review of the
literature he concluded statins have not been proven to
have a net health benefit in most patients taking them
today.
Martin L. Pall, PhD
Professor—Biochemistry and Basic Medical Sciences,
Washington State University.
E-mail: martin_pall@wsu.edu
The NO/NOO cycle as the cause of previously unex-
plained illnesses: etiology and effective therapy
Related overlapping illnesses including chronic fatigue
syndrome, multiple chemical sensitivity, fibromyalgia
and post-traumatic stress disorder appear to be caused
by a novel paradigm of human disease known as the
NO/NOO cycle.
The NO/NOO cycle involves the interaction of Nitric
Oxide with superoxide to produce a quite damaging
radical: peroxynitrite. Dr Pall reviewed how this model is
based on five distinct principles which may in fact help
explain the pathogenesis of many inflammatory diseases
including: Alzheimer’s, Multiple Sclerosis, Autism, Asthma
and Parkinson’s disease. He suggested that short-term
stressors raise nitric oxide levels and initiate this vicious
cycle that is self-perpetuating and quite damaging to
mitochondria. In order to treat these disorders, one
must deal with the major oxidative stressors in this
NO/NOO cycle. He then reviewed promising agents for
down regulation of this cycle and the data supporting their
rational use. Those with clinical trial data include: ascorbic
acid, flavonoids, Acetyl-L-carnitine, mitochondrial regen-
eration agents, B12, folic acid, NMDA antagonists,
Long chain omega 3 fatty acids, Algal supplements,
glutathione, magnesium, and hyperbaric oxygen.
Roberts W. Summers, MD, James A. Clifton
Professor of Medicine Gastroenterology/Hepatology
Division—Iowa Department of Internal Medicine.
E-mail: robert-summers@uiowa.edu
Back to the future: Helminth Ova Therapy in IBD
‘The etiology of inflammatory bowel disease represents
the interplay between genetic and environmental factors.
Helminths have been shown to modulate immune
response in animals and protect mice from developing
experimentally-induced IBD.’ Dr Summers reviewed data
showing that in 54 subjects with ulcerative colitis enrolled
in a 12-week double-blind placebo controlled clinical
trial, 45% of Porcine whipworm ova-treated subjects had
a positive response to therapy compared with only 17%
in placebo controls. In 29 patients with Crohn’s disease,
62% achieved remission after 12 weeks and 76% achiev-
ed a clinical response. No significant side effects or
complications were identified making this a very promis-
ing treatment in a variety of immune-mediated difficult to
control diseases.
Bill Cham, PhD
‘The Eggplant Cancer Cure: A Treatment for Skin
Cancer and New Hope for Other Cancers from
Nature’s Pharmacy’. E-mail: bill.cham@gmail.com
416 Meeting ReportWhen does alternative become orthodox? Skin cancer
treatment with solasodine rhamnosyl glycosides in its
transitional stage, a case study.
Dr Cham’s work centers on ‘Devil’s Apple’ derived
glycoalkaloids, specifically solasodine rhamnosyl glyco-
side. He has discovered that many tumors contain recep-
tors for this glycoalkaloid and exhibit a unique binding
increasing their susceptibility to its killing effect without
harming normal cells. The constant ratio of solasodine
glycosides (now known as BEC) available in ‘Devil’s
Apple’ have been shown to be non-toxic to normal cells
and dramatically reduce the growth of many tumor cells ex-
vivo including ovarian and squamous cell tumors among
others. BEC or its main compound solamargine, is
reported to show much higher antineoplastic activity and
lower toxicities than vinblastin, cisplatin, doxorubicin and
camptothecin and should result in a higher therapeutic
window when used in the treatment of cancer. He presented
data in mice with terminal sarcoma showing that four
doses of BEC resulted in >90% survival rates. Other
promising tumor responses have been seen with melanoma
and merkel cell tumors.
A small phase II clinical trial in humans composed of
40 patients with late stage disease including: glioblastoma
multiforme, colon cancer, bladder cancer, liver cancer,
metastasized melanoma to the lung and rectal cancer
showed improvement in appetite, tumor reduction,
improved quality of life and extended life span.
Additionally, the results of Phase 3 clinical trials utilizing
BEC topically for skin cancers showed an impressive
100% success rate at 12 weeks of treatment.
Steve Kaufman DC
Author of 75 papers on the topics of nutrition,
acupuncture and soft tissue therapies, Dr Kaufman
practices in Denver, Colorado, USA.
E-mail: drstephenkaufman@axint.net
Pain neutralization technique: using neurological reflexes
to stop musculoskeletal pain instantly, without needles or
electronics
Dr Kaufman presented a new method of quickly
neutralizing areas of palpatory pain often known as
trigger points. With participants on stage he reviewed
the nature and definition of trigger points, the three
types of pain described as (i) spontaneous pain, (ii) pain
on movement and (iii) palpatory pain. He then demon-
strated the benefits of his techniques by identifying
and manipulating neurological reflexes in a hands on
fashion.
Floyd H. ‘Ski’ Chilton, III PhD
Professor—Department of Physiology and Pharmacology
and Director of the Wake Forest and Brigham and
Women’s Center for Botanical Lipids—Wake Forest
University Health Sciences.
E-mail: schilton@wfubmc.edu
The role of natural bioactive for the prevention and
treatment of chronic human diseases
Dr Chilton reviewed five key nutritional trends that have
taken place in our lifetime and likened them to the
perfect storm for poor health. These include: (i) increased
calories (ii) reduced fiber (iii) decreased exercise
(iv) decreased dietary polyphenols and (v) an increase
in dietary omega 6 fatty acids and reduction in dietary
omega 3 fatty acids. He noted that most of these trends
have been driven by a marked change in our food supply
and lays the major illnesses in this country such as
asthma, obesity, heart disease, psoriasis and diabetes
squarely at their feet.
He reviewed the data on how obesity increases the
levels of inflammatory cytokines such as IL1B, TNF-
alpha and IL-6. He discussed bioactive compounds in our
foods: compounds not necessary for life as are nutrients,
but compounds which act as enzyme inhibitors and
inducers, inhibitors and inducers of receptor activities
and inhibitors of gene expression. Reviewing the concept
of nutrigenomics (using or avoiding foods to regulate
transcriptional factors and subsequent gene expression)
Dr Chilton placed NFkB in the middle of controlling our
immune response and noted that incorrect control of this
transcription factor is key to the development of disease.
He ended the lecture discussing the various bioactives
and their ability to ameliorate disease. From polyphenols
to Omega 3 fatty acids, the future promise of better
health seems clear if we can reconstitute our foods:
genetically speaking. Unfortunately, it appears this will
come in the form of patented medical foods that extract a
considerable financial price. This indeed was my only
disappointment with an otherwise excellent lecture.
Lewis Mehl-Madrona, MD, PhD, MPhil
Associate Professor of Family Medicine and Psychiatry—
University of Saskatchewan College of Medicine.
E-mail: coyotecanada@aol.com
Traditional healing, alternative medicine and diabetes
According to Dr Mehl-Madrona, aboriginal populations
have undergone dramatic transformations of culture and
lifestyle within the last half-century leading to increases in
many diseases, most notably diabetes. In this lecture,
Dr Mehl-Madrona reviewed the role of emotional stress
and socioeconomic status in the onset of diabetes. He
suggests addressing low levels of autonomy and low self-
esteem may be two important means of improving
management of diabetes as evidenced by a pilot study on
the efficacy of lifestyle interventions among the Pima tribe
of Arizona.
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Specialist in interventional pain management and regen-
erative medicine. Author-A New Prescription for
Addiction. E-mail: Richard@gracermd.com
A new prescription for addiction
Dr Gracer accurately identified the flaws in the current
treatment of addiction and proposed a number of specific
solutions to correct these deficits. He noted that nutri-
tional deficiencies were often not addressed and included
the assessment of hormonal and neurotransmitter func-
tion as an important aspect of his evaluation. Dr Gracer
referenced studies, which consistently demonstrate a
combination of pharmacotherapy, psychosocial interven-
tion and nutrition education are more successful than
current interventions.
Alcohol and cocaine clearly have an impact on cerebral
blood flow and neurotransmitter function based on SPECT
scanning. Additionally, they impact GABA receptors in an
adverse way. Considering that nearly 40% of all brain
synapses are GABA this has profound implications for
addiction. Dr Gracer reviewed the increased expression of
alpha 4 subunits in GABA receptor sites with the excess
use of alcohol, cocaine, and methamphetamine citing
the alpha 4’s tendency to exacerbate cravings and with-
drawal symptoms. Normalizing the ratio of GABA alpha
1–alpha 4 receptor subunits is a promising approach to
treating anxiety and addictive behavior. He showed the
potential benefit of using flumazenil a benzodiazepine
antagonist to treat methamphetamine-dependent subjects.
Methamphetamine usage was significantly reduced up to
2 months after cessation of medication in one study and
80% of cocaine addicts remained drug free for at least 180
days in another.
Jeffrey Blumberg, PhD, FACN, CNS
Professor-Friedman School of Nutrition and Science and
Policy. Director-Antioxidants Research Laboratory Tufts
University. E-mail: jeffrey.blumberg@tufts.edu
Evidence-based nutrition and the problem of proof
‘The randomized controlled clinical trial is now the ‘gold
standard’ not only for establishing the efficacy and safety
of drug therapies but also for recommending changes
in diet and the use of dietary supplements’ says
Dr Blumberg. ‘There are however problems with this
approach considering the long latency and multifactorial
causation of chronic disease and the impossibility of a
zero exposure to a nutrient (for a placebo).’ Additionally,
the multiple thresholds for different actions of a single
nutrient in various tissues limit the value and the
application of randomized controlled trials to test
nutrition hypotheses. Quoting Concato et al., N Engl J
Med 2000, Dr Blumberg noted, ‘the popular belief that
only randomized controlled trials produce trustworthy
results and that all observational studies are misleading
does a disservice to patient care, clinical investigation,
and education of health care professionals’ And again,
Benson and Hartz, N Engl J Med 2000 in their
comparison of 136 Observational Studies and RCTs
(Randomized Controlled Trials) ‘We found little evidence
that estimates of treatment effects in observational
studies reported after 1984 are either consistently larger
than or qualitatively different from those obtained in
randomized, controlled trials’. Lastly, Heaney, Am J Clin
Nutr 2006, ‘The randomized controlled trial, which has
become the gold standard for establishing the efficacy of
pharmacologic agents, is poorly suited to the evaluation
of nutritional effects, a fact that I believe many have
been reluctant to acknowledge.’ He then covered the
NIH State-of-the Science Conference on Multivitamin/
Mineral Supplements and Chronic Disease Prevention.
‘The present evidence is insufficient to recommend either
for or against the use of (Multi Vitamins and Minerals) by
the American public to prevent chronic disease.’ And how
did the NIH arrive at this conclusion Dr Blumberg asks?
A literature search process identified 11324 citations
from 1996 to February of 2006 that were potentially
relevant to the key questions. These citations were found
through MEDLINE, EMBASE, Cochrane database, etc.
According to AHRQ Publication No. 06-EOI2, May
2006, the review process for eligibility and study quality
assessment excluded consideration of 11,261 reports, so the
final report and recommendations were based on only
63 articles.
Might there be bias in these recommendations? The
publication did admit that ‘Limiting the focus of our
statement to RCTs has some inherent limitation.’ Indeed!
Dr Blumberg is to be commended for this excellent
review of the limitations the randomized controlled trial
places on the evaluation of nutrients and their ability to
prevent chronic disease.
Frank Antonawich, PhD
Associate Professor and Chairman Department of
Biology St. Joseph’s College New York.
E-mail: frank@garnettmckeenlabs.net
The metabolic role of palladium lipoic acid complex in
mitochondrial health and subsequent regulation of cellular
death
Dr Antonawich, reviewed the biochemistry of Palladium
Lipoic Acid Complex (PdLA). PdLA is a nutritional
supplement that is unique to free radical biology since
palladium is a transition metal that can catalyze aerobic
respiration, thus mimicking the electron transport chain.
Research studies with PdLA a novel redox molecule have
demonstrated its ability to take advantage of the
418 Meeting Reportmetabolic dysfunction of cancer cells by increasing their
susceptibility to apoptosis. Additionally, being a redox
molecule and a potent free radical scavenger PdLA
attenuates reperfusion injury by lessening the impact
of free radicals on damaged tissues and implying a role
in stroke and other reperfusion induced injuries. In an
animal study published in Free Radical Biology and
Medicine, 2007, Dr Atonawich has shown that after an
episode of transient global ischemia, PdLA rescues 80%
of the hippocampal neurons when administered at the
time of insult.
The history of cancer bioenergetics including the
Warburg effect was reviewed. Dr Atonawich detailed
the view of modern molecular biology: cancer is more a
disease of genetics, not bioenergetics. Yet, more recent
research from the NIH suggests mutations in the p53
gene (commonly linked to cancer) can trigger the
Warburg effect leading to abnormal bioenergetics. It is
at this crossroad that PdLA may play a role. In cancer,
hypoxia triggers a series of physiologic adaptations to
this environment via Hypoxia Inducible Factor (HIF).
This metabolic dysfunction restricts malignant cells
forcing them to rely on anaerobic metabolism (glycolysis)
for energy, which is extremely inefficient. By providing an
alternative electron source in a hypoxic state such as
PdLA, cancer calls cannot survive and die while normal
cells are supplemented by it and thrive. PdLA appears to
kill cancer cells by facilitating apoptosis.
Allan B. Warshowsky, MD
Board certified OB/GYN. Author- Healing Fibroids
A Doctors Guide To A Natural Cure.
E-mail: dr@doctorallan.com
Healing fibroids: a doctors guide to a natural cure
Dr Warshowsky attempted to demonstrate how disorders
of inflammation, immune response, sugar metabolism,
intestinal function and detoxification affect hormone
balance and the growth of fibroid tumors. He suggests
that proper diet and nutrition, exercise, and stress
management can benefit hormone balance and inflam-
mation reducing the need for invasive procedures with
uterine fibroids.
Dr Warshowsky reviewed the symptoms of estrogen
dominance and how this condition was made worse by
impaired detoxification, glucose dysregulation, and intest-
inal dysbiosis. Reviewing a small study of 37 women in
which his methods were applied, he noted a cure of
fibroids in three patients and a mean reduction in size
of 0.8cm compared with an average increase in size of
1.9cm in controls. He reviewed a number of herbal
products felt to be supportive in the quest to prevent or
reduce uterine fibroids.
Katherine Falk, MD
Assistant Clinical Professor of Psychiatry Mount
Sinai School of Medicine.
E-mail: katherinefalkmd@gmail.com
Integrative therapy of depression, anxiety and bipolar
disorder.
Dr Falk’s lecture centered on facilitation of proper
neurotransmitter function in the setting of depression
and bipolar disorder. She reviewed neurotransmitter
production and the varied nutrients involved as cofactors
in their synthesis as well as the impact of Omega 3 fatty
acids in depression noting that too much EPA may lead
to an agitating influence in bipolar disorder while DHA
exerts a more calming effect.
She discussed the neuroprotective role of lithium and its
ability to stimulate neuronal growth, even in small
dosages. She reviewed the benefit of SAMe in methyl
donation in over 35 reactions and its necessity in over 100
biochemical reactions. She acknowledged that SAMe may
induce mania and must be properly monitored. The
adverse effects of St. John’s Wort were reviewed and the
benefit of T3 preparations as a potential neurotransmitter
were discussed.
George Gillson, MD, PhD
President and CEO—Rocky Mountain Analytical Lab.
E-mail: Gillson@rmalab.com
Transmethylation reactions: critically important, often
overlooked
In this lecture, Dr Gillson reviewed the role of common
methyl donors including: (i) S-AdenosylMethionine
(SAMe), (ii) Trimethylglycine (TMG), (iii) 5-methyltetra
hydrofolate(MTHF), (iv) Methylcobalamin(MethylB12)
and (v)Methylsulfonylmethane (MSM).
Transmethylation reactions are integral in histamine
metabolism, methionine cycling, adrenal function, neuro-
transmitter balance, myelin stability, estrogen and cate-
cholamine metabolism, cell membrane structure and liver
detoxification. Dr Gillson reviewed the importance of
SAMe in inactivating histamine thereby successfully
neutralizing histamine mediated reactions such as hives
and excess acid secretion. He noted the role of elevated
homocysteine in many diseases and how it could be
reduced using methyl donors. He reviewed liver detox-
ification and the importance of methylsufonation in
clearing PCBs. Other notable roles of methyl donors
include protection from CCl4 exposure, reduction of
alcoholic fatty liver (betaine) and prevention of cirrhosis
(SAMe). An excellent lecture.
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Author of five books on Integrative and Nutritional
Medicine. Technical editor—Journal of the American
Nutraceutical Assocation. E-mail: roundoc@qwest.net
Enhancing detoxification with glucosinolates from Brassica
vegetables.
Broccoli, cabbage, cauliflower, collards, kale and brussel
sprouts were just a few of the Brassica vegetables that
Dr Rountree noted to be helpful in aiding detoxification.
Briefly reviewing the consensus of 300 case control
studies he summarized their conclusions. Brassica vege-
tables show a protective effect against cancer in the
respiratory tract, the gastrointestinal tract, the genitour-
inary tract and the reproductive organs. When compared
with fruits and vegetables in general, cruciferous vege-
tables have a better reduction in relative risk for bladder
cancer than any other group. He noted the key groups of
protective compounds in Brassica vegetables are the
glucosinolates and their derivatives, isothiocyanates,
which are responsible for modulating Phase I and
Phase II enzymes. They have been shown to have direct
effects on human cancer cells in addition to shifting
estrogen metabolism toward healthier 2OH estrogens.
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